Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-03-14 to 2017-04-06
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
July 21, 1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
30 May 2008
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N'-methylenebis[methacrylamide]
EC Number:
219-102-3
EC Name:
N,N'-methylenebis[methacrylamide]
Cas Number:
2359-15-1
Molecular formula:
C9H14N2O2
IUPAC Name:
N,N'-methylenebis(2-methylacrylamide)
Test material form:
solid: particulate/powder
Details on test material:
- Designation: N,N’-Methylene-bis-methacrylamide
- Chemical name: 2-Propenamide, N,N’-methylene-bis (2-methyl)
- Characteristics: white powder
- Storage conditions: at room temperature in the dark

Method

Target gene:
histidine operon
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 98
Additional strain / cell type characteristics:
other: uvrB-, rfa-, pKM 101, resistance to Ampicillin
Species / strain / cell type:
S. typhimurium TA 100
Additional strain / cell type characteristics:
other: uvrB-, rfa-, pKM 101, resistance to Ampicillin
Species / strain / cell type:
S. typhimurium TA 102
Additional strain / cell type characteristics:
other: wild-type, rfa-, pKM 101/pAQ1, resistance to Ampicillin
Species / strain / cell type:
S. typhimurium TA 1535
Additional strain / cell type characteristics:
other: uvrB-, rfa-, non-resistance to Ampicillin
Species / strain / cell type:
S. typhimurium TA 1537
Additional strain / cell type characteristics:
other: uvrB-, rfa-, non-resistance to Ampicillin
Metabolic activation:
with and without
Metabolic activation system:
S9 fraction, Aroclor 1254-induced, from male Sprague-Dawley rat liver (Trinova Biochem GmbH, Gießen, Germany)
Test concentrations with justification for top dose:
In two preliminary cytotoxicity tests (plate incorporation test without and with metabolic activation) in test strain TA100, no signs of cytotoxicity were noted up to the top concentration of 5000 µg/plate. Ten concentrations ranging from 0.316 to 5000 µg/plate were tested. Hence, 5000 µg/plate were chosen as top concentration for the main study.
Vehicle / solvent:
- Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: test substance could be completely dissolved in DMSO.
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
benzo(a)pyrene
mitomycin C
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation
- Cell density at seeding: 0.1 mL of approximately 1.00E+08 viable cells in the late exponential or early stationary phase
DURATION
- Preincubation period: 20 minutes at 37°C
- Exposure duration: 37°C for 48 h
NUMBER OF REPLICATIONS:
- Plates: 3 per concentration and experiment
- Experiments: 2 independent experiments, each with and without metabolic activation
DETERMINATION OF CYTOTOXICITY
- Method: Cytotoxicity is evidenced by a reduction in the number of spontaneous revertants by at least 50%, a clearing or diminution of the background lawn or by the degree of survival of the treated cultures. Insolubility could have been assessed as precipitation in the final mixture under the actual test conditions and evident to the unaided eye.
Evaluation criteria:
Acceptance Criteria:
The results of the negative and positive control cultures should be within the range of the historical data. The range of spontaneous reversion frequencies per plate is based on Kirkland (1990):
TA98: 20-60
TA100: 100-200
TA102: 240-320
TA1535: 10-35
TA1537: 3-20
Where concurrent negative or positive control data fall outside the range, they may be acceptable and considered for the inclusion into the historical control distribution as long as these data are not extreme outliers. Historical background data of revertant colony numbers of the negative and positive controls without and with metabolic activation for the experiments of the years 2015 to 2017 are given in Table 1 in section "any other details on results incl. tables".
Statistics:
Interpretation of results:
A test item is considered to show a positive response if
- the number of revertants is significantly increased (p ≤ 0.05, U-test according to MANN and WHITNEY) compared to the solvent control to at least 2-fold of the solvent control for TA98, TA100, TA1535 and TA1537 and 1.5-fold of the solvent control for TA102 in both independent experiments.
or
- a concentration-related increase over the range tested in the number of the revertants per plate is observed. The Spearman's rank correlation coefficient may be applied.
- positive results have to be reproducible and the histidine independence of the revertants has to be confirmed by streaking random samples on histidine-free agar plates.
Biological relevance of the results should be considered first. A test item for which the results do not meet the above mentioned criteria is considered as non-mutagenic in the AMES test.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: not described
- Effects of osmolarity: not described
- Evaporation from medium: not described
- Water solubility: test item could be completely dissolved in DMSO
- Precipitation: none reported
RANGE-FINDING/SCREENING STUDIES:
Two preliminary cytotoxicity tests (plate incorporation test without and with metabolic activation) in test strain TA100 were conducted. Ten concentrations ranging from 0.316 to 5000 µg/plate were tested. No signs of cytotoxicity were noted up to the top concentration of 5000 µg/plate. Hence, 5000 µg/plate were chosen as top concentration for the main study in the plate incorporation test and in the preincubation test.
HISTORICAL CONTROL DATA: please see section “any other information on results incl. tables”.

Any other information on results incl. tables

Preliminary test

The test item was examined in two preliminary cytotoxicity tests (plate incorporation test without and with metabolic activation) in test strain TA100. Ten concentrations ranging from 0.316 to 5000 µg/plate were tested. No signs of cytotoxicity were noted up to the top concentration of 5000 µg/plate (see tables 2 and 3). Hence, 5000 µg/plate were chosen as top concentration for the main study in the plate incorporation test and in the preincubation test.

Main study

Six concentrations ranging from 31.6 to 5000 µg/plate were employed in the plate incorporation test and in the preincubation test, each carried out without and with metabolic activation.

Cytotoxicity 

No signs of cytotoxicity were noted in the plate incorporation test and in the preincubation test, each carried out without and with metabolic activation, up to the top concentration of 5000 µg/plate in any test strain.

Mutagenicity

No increase in revertant colony numbers as compared with control counts was observed tested up to a concentration of 5000 µg/plate, in any of the 5 test strains in two independent experiments without and with metabolic activation, respectively (plate incorporation test and preincubation test). The positive control items showed a significant increase in the number of revertant colonies of the respective test strain and confirmed the validity of the test conditions and the sensitivity of the test system. The results of the negative and positive control cultures are within the range of the historical data (see table 1). The slightly higher value of revertant colony numbers of test strain TA1535 in all experiments (266.0 to 400.0) compared to the historical positive control data (49 to 270) is considered to be within the normal variation, as the mutation frequency is compatible with those generated in the historical positive control data base and produce a statistically significant increase compared with the concurrent negative control. 

A summary of the results is given below in tables 4 to 7.

HISTORICAL CONTROL DATA

Table 1: history profile of negative and positive control values of the years 2015 to 2017 (n= 80 studies). Data obtained from plate incorporation and preincubation tests

Negative reference item

Strain

TA 98

TA 100

TA 102

TA 1535

TA 1537

S9-mix

-S9

+ S9

-S9

+ S9

-S9

+ S9

-S9

+ S9

-S9

+ S9

Mean

30.3

32.1

145.1

145.2

277.3

279

19.7

19.9

6.7

6.7

SD

5.6

5.9

18.4

19.2

16.5

17.2

4.4

4.6

1.7

1.8

Min

20

20

107

101

245

203

10

10

2

3

Max

49

49

195

198

323

324

36

36

10

10

Positive reference item

Strain

TA 98

TA 100

TA 102

TA 1535

TA 1537

S9-mix

-S9

+ S9

-S9

+ S9

-S9

+ S9

-S9

+ S9

-S9

+ S9

 

2-nitro-fluorene

Benzo[a]-pyrene

Sodium azide

2-amino-anthracene

Mitomycin C

Benzo[a]-pyrene

Sodium azide

2-amino-anthracene

9-amino-acridine

Benzo[a]-pyrene

Mean

151.2

150.4

952.9

948.8

1029.7

1024.3

135.6

135.4

76.7

77.6

SD

27.9

28.8

99.7

103.7

102.3

97.1

28.8

28.4

26.5

26.4

Min

91

96

677

703

756

781

51

49

28

31

Max

293

291

1213

1195

1637

1366

266

270

185

184

Table 2: Preliminary cytotoxicity test without metabolic activation. Plate incorporation test with TA 100.

Test item (µg/plate)

Background lawn

Revertants plate 1

Revertants plate 2

0.316

normal

107

133

1

normal

130

130

3.16

normal

152

171

10

normal

171

163

31.6

normal

167

170

100

normal

170

168

316

normal

175

130

1000

normal

162

160

3160

normal

176

188

5000

normal

185

184

Solvent control

100 µL/plate

normal

118

145

 

Table 3: Preliminary cytotoxicity test with metabolic activation. Plate incorporation test with TA 100.

Test item (µg/plate)

Background lawn

Revertants plate 1

Revertants plate 2

0.316

normal

156

157

1

normal

175

176

3.16

normal

152

169

10

normal

174

141

31.6

normal

113

174

100

normal

171

172

316

normal

133

134

1000

normal

165

163

3160

normal

187

188

5000

normal

137

187

Solvent control 100 µL/plate

normal

 

132

 

Table 4: Plate incorporation test without metabolic activation

Test item (µg/plate)

Number of reverted colonies (mean values, n=3)

 

TA98

TA100

TA102

TA1535

TA1537

31.6

26

134

276.3

16.3

6.7

100

29.7

129.7

270.7

15

6.7

316

34.7

147

283

16

5.7

1000

28.7

137

287

15

5.7

3160

28.3

137

269.7

18

8.7

5000

31

152.7

301.3

13

9

Negative reference item

100 µL/plate

28.7

158.3

297.3

22.3

8

Positive reference item

2-nitro-fluorene

Sodium azide

Mitomycin C

Sodium azide

9-amino-acridine

Concentration

µg/plate

10

10

10

10

100

 

154.3

943.3

962.7

323

107.7

 

Table 5: Plate incorporation test with metabolic activation

Test item (µg/plate)

Number of reverted colonies (mean values, n=3)

 

TA98

TA100

TA102

TA1535

TA1537

31.6

26.3

137.7

280.3

22

7.3

100

30.3

134.7

276

19.3

5

316

33.7

145.3

287.7

12.7

5.7

1000

33

137.7

280.3

15.3

5

3160

30.7

145

273

14.3

5.3

5000

32.3

137.7

303.7

18.3

5

Negative reference item

100 µL/plate

29

159

304

15

4.7

Positive reference item

Benzo[a]pyrene

2-amino-anthracene

Benzo[a]pyrene

2-amino-anthracene

Benzo[a]pyrene

Concentration

µg/plate

10

2

10

2

10

 

159.7

946

926.3

400

105

 

Table 6: Preincubation test without metabolic activation

Test item (µg/plate)

Number of reverted colonies (mean values, n=3)

 

TA98

TA100

TA102

TA1535

TA1537

31.6

26

158.3

268

18.3

5.3

100

28

140

271.3

18

7.3

316

37.3

130.3

291.7

15

5

1000

28.3

144.7

243

13.7

6.3

3160

24.7

156

263.3

19

8.3

5000

34

162.3

296.3

15.3

7.7

Negative reference item

100 µL/plate

32.7

165.7

280.7

26.3

7.3

Positive reference item

2-nitro-fluorene

Sodium azide

Mitomycin C

Sodium azide

9-amino-acridine

Concentration

µg/plate

10

10

10

10

100

 

154.3

989.7

1032.7

302.7

92.3

 

Table 7: Preincubation test with metabolic activation

Test item (µg/plate)

Number of reverted colonies (mean values, n=3)

 

TA98

TA100

TA102

TA1535

TA1537

31.6

33.3

124.7

278.3

21.3

6.3

100

31.3

131.3

282.3

20

5

316

33.3

119.7

286

20

7

1000

35

128

294.3

14.3

5.7

3160

30.7

131

282.7

16

7

5000

29.3

139

287

13.7

8.7

Negative reference item

100 µL/plate

27.7

144

262.7

26.7

7.7

Positive reference item

Benzo[a]pyrene

2-amino-anthracene

Benzo[a]pyrene

2-amino-anthracene

Benzo[a]pyrene

Concentration

µg/plate

10

2

10

2

10

 

151.7

1052.7

1095

266

103.3

 

 

Applicant's summary and conclusion

Conclusions:
Under the present conditions, the test substance tested up to a concentration of 5000 µg/plate caused no mutagenic effect in the Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 neither in the plate incorporation test nor in the preincubation test each carried out without and with metabolic activation. Thus, the test item is considered to be non-mutagenic in the bacterial reverse mutation assay.
Executive summary:

The potential of N,N'-methylenebis[methacrylamide] to induce gene mutations was examined in 5 Salmonella typhimurium strains (TA98, TA100, TA102, TA1535 and TA1537) without and with metabolic activation (S9-fraction derived from Aroclor 1254-induced rat liver). The first experiment was carried out as a plate incorporation test and the second as a preincubation test. DMSO was employed as the negative control.

In a preliminary test, no signs of cytotoxicity were noted up to the top concentration of 5000 µg/plate. In the main study, six concentrations ranging from 31.6 to 5000 µg/plate were employed in the plate incorporation test and in the preincubation test, each carried out without and with metabolic activation. No signs of cytotoxicity were noted in the plate incorporation test and in the preincubation test, each carried out without and with metabolic activation, up to the top concentration in any test strain.

No increase in revertant colony numbers as compared with control counts was observed for the test item, tested up to a concentration of 5000 µg/plate, in any of the 5 test strains in two independent experiments without and with metabolic activation, respectively (plate incorporation test and preincubation test).

The positive control items showed a significant increase in the number of revertant colonies of the respective test strain and confirmed the validity of the test conditions and the sensitivity of the test system.

ln conclusion, under the present test conditions, the test substance tested up to a concentration of 5000 µg/plate caused no mutagenic effect in the Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 neither in the plate incorporation test nor in the preincubation test each carried out without and with metabolic activation.